Skip to content

Clareon CNWET6 (UDI 00380652467445)Recalls & reported problems

Alcon Laboratories, Inc. · Clareon Vivity Toric · Class 3 · Implant

All models of Clareon (1142)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00380652467445), received between Dec 31, 2025 and Apr 24, 2026 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 1 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 1 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Break1
  • Failure to Deliver1

Patient problems

  • Blurred Vision1
  • No Clinical Signs, Symptoms or Conditions1
  • Visual Impairment1
  • Vitreous Floaters1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryApr 24, 2026Adverse Event Without Identified Device or Use Problem

    A CONSUMER REPORTED THAT AFTER CATARACT SURGERY WITH INTRAOCULAR LENS (IOL) IMPLANTATION IN THE LEFT EYE, HIS VISION WAS NOT GOOD AS EXPECTED. AT FIRST HIS VISION WAS 20/20 IN EACH EYE. HOWEVER, A WEEK AFTER SURGERY, HIS VISION DECREASED. HE EXPERIENCED MASSIVE FLOATERS WHICH WERE NOT PRESENT BEFORE THE PROCEDURE. HE WAS PRESCRIBED GLASSES WHICH HELPED HIM SEE BETTER. BASED ON ADDITIONAL INFORMATION RECEIVED ON 27-MAR-2026: THE LENS WAS REMOVED AND REPLACED WITH A MONOFOCAL LENS IN A SECONDARY PROCEDURE. THE PATIENT REQUESTED THE EXPLANT BECAUSE HE WAS UNHAPPY WITH THE VISION. CLINICALLY, THE EXPLANT WAS INDICATED FOR THE SAME REASON, AND ADDITIONALLY BECAUSE THE PATIENT REQUIRED A HIGHER TORIC POWER.

    Patient problems: Blurred Vision; Visual Impairment; Vitreous Floaters

    MAUDE report 24977120 ↗
  • MalfunctionDec 31, 2025Break; Failure to Deliver; Break; Failure to Deliver

    A NURSE REPORTED THAT DURING AN INTRAOCULAR LENS (IOL) IMPLANTATION PROCEDURE, THE LENS WAS OPENED AND LOADED INTO THE COMPANY INJECTOR WITH COMPANY CARTRIDGE. DURING THE PUSHING STAGE, IT WAS OBSERVED THAT THE ANTERIOR HAPTIC HAD ADHERED TO THE CARTRIDGE, PREVENTING THE INJECTOR FROM ADVANCING. THE LENS WAS REMOVED FROM THE CARTRIDGE USING FORCEPS, AND UPON INSPECTION, THE ANTERIOR HAPTIC WAS FOUND TO BE BROKEN. THE PROCEDURE WAS SUCCESSFULLY COMPLETED USING ANOTHER LENS OF THE SAME DIOPTER. THE PATIENT¿S EYE WAS NOT AFFECTED IN ANY WAY. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23932632 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page